1-3 of 3
Cecilia Becattini
Close
Sort by
Journal Articles

DOACs in patients with brain cancers: promising but still a long way to go

Michela Giustozzi, Cecilia Becattini, Fausto Roila, Giancarlo Agnelli, Mario Mandalà
Journal: Blood Advances
Blood Adv (2023) 7 (2): 283–284.
https://doi.org/10.1182/bloodadvances.2022009192
Published: 2023
Journal Articles

ICH in primary or metastatic brain cancer patients with or without anticoagulant treatment: a systematic review and meta-analysis

Michela Giustozzi, Giulia Proietti, Cecilia Becattini, Fausto Roila, Giancarlo Agnelli, Mario Mandalà
Journal: Blood Advances
Blood Adv (2022) 6 (16): 4873–4883.
https://doi.org/10.1182/bloodadvances.2022008086
Published: 2022
Includes: Supplemental data
Journal Articles

Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study

Clinical Trials & Observations
Walter Ageno, Jan Beyer Westendorf, Laura Contino, Eugenio Bucherini, Maria Teresa Sartori, Marco Senzolo, Elvira Grandone, Rita Santoro, Marc Carrier, Aurélien Delluc, Valerio De Stefano, Fulvio Pomero, Marco Paolo Donadini, Alberto Tosetto, Cecilia Becattini, Ida Martinelli, Barbara Nardo, Laurent Bertoletti, Marcello Di Nisio, Alejandro Lazo-Langner, Alessandro Schenone, Nicoletta Riva
Journal: Blood Advances
Blood Adv (2022) 6 (12): 3569–3578.
https://doi.org/10.1182/bloodadvances.2022007397
Published: 2022
Includes: Supplemental data